Global Lateral Flow POC Reader Market to Hit USD 688 Million by 2032 According to a newly published market research report by 24LifeSciences, global lateral flow POC reader market was valued at USD 557 million in 2024 and is projected to reach USD 688 million by 2031, growing at a compound annual growth rate (CAGR) of 3.1% during the forecast period 2025–2031. Lateral Flow POC Readers are instrumental diagnostic devices designed for the qualitative and quantitative analysis of lateral flow assays, which are widely used immunological rapid tests for point-of-care diagnostics. These readers transform simple visual test strips into objective, data-driven tools, enabling precise measurement of analytes across diverse fields such as infectious disease testing, cardiac marker analysis, drug screening, and veterinary diagnostics. This technology is crucial for delivering rapid, accurate results outside of central laboratories, empowering healthcare decisions at the point of need. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7472/lateral-flow-poc-reader-market

Combined Cotton-Filled Dressings Market Forecast to 2032 According to a newly published market research report by 24LifeSciences, global combined cotton-filled dressings market was valued at USD 346.8 million in 2024 and is projected to grow to USD 482.1 million by 2032, expanding at a compound annual growth rate (CAGR) of 4.2% during the forecast period 2025–2032. Combined cotton-filled dressings are advanced wound care products specifically engineered for managing moderate to heavily exuding wounds. These dressings incorporate a highly absorbent coretypically medical-grade cotton often blended with materials like rayon or polyesterenclosed within a soft, non-woven facing. This design efficiently draws and locks away excess exudate while preventing strike-through and maintaining an optimal moist wound healing environment. Sterile and intended for single-use, they serve as a versatile solution for various wound types, including surgical sites, pressure ulcers, and leg ulcers. Their value lies in delivering superior absorbency, sterility, and effective exudate management. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10692/combined-cotton-filled-dressings-market

Top 7 Innovations in the Anti-Peptic Ulcer Drugs Industry According to a newly published market research report by 24LifeSciences, global anti-peptic ulcer drugs market was valued at USD 10.21 billion in 2024 and is projected to reach USD 25.80 billion by 2031, growing at a compound annual growth rate (CAGR) of 14.5% during the forecast period 2025–2031. Anti-peptic ulcer drugs encompass a range of pharmaceutical agents that prevent, manage, or heal ulcers in the stomach and duodenum. This market includes several drug classes with distinct mechanisms of action, such as proton pump inhibitors (PPIs) that profoundly suppress acid production, H2 receptor antagonists that reduce acid secretion, antacids that neutralize existing stomach acid, and mucosal protective agents that strengthen the stomach's natural defenses. The established efficacy of these drugs, particularly in managing conditions like gastroesophageal reflux disease (GERD), gastric ulcers, and duodenal ulcers, continues to underpin their critical role in gastroenterological practice worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7579/anti-peptic-ulcer-drugs-market-market

Cell Staining Solution Market Outlook 2025: Life Science Trends According to a newly published market research report by 24LifeSciences, global cell staining solution market was valued at USD 241 million in 2024 and is projected to reach USD 355 million by 2031, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period. Cell staining solutions, encompassing a diverse array of chemical reagents and formulations, are essential tools for visualizing specific cellular structures, components, or functions under microscopy. These critical research components serve as the foundation for diagnostic pathology, advanced research methodologies, and comprehensive drug development workflows across global laboratories. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5047/cell-staining-solution-market

Top 10 Key Players Transforming the Hemostatic Agents Market (2025–2032) According to a newly published market research report by 24LifeSciences, global hemostatic agents market was valued at USD 3.65 billion in 2024 and is projected to reach USD 5.88 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 2025-2032. Hemostatic agents are critical medical products used as an adjunct or alternative to standard suturing and cauterization techniques to control bleeding during surgical procedures and in trauma care. These agents work by promoting rapid clot formation at the site of bleeding and include product segments such as gelatin sponges, oxidized regenerated cellulose based hemostats, collagen-based agents, and combination hemostats. Their established efficacy in achieving hemostasis continues to underpin their essential role across various surgical specialties, including cardiovascular, orthopedic, and emergency medicine. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/1056/hemostatic-agents-market-market

What Is the Future of the Immune Health Ingredient Market? Insights to 2032 According to a newly published market research report by 24LifeSciences, global immune health ingredient market was valued at USD 23.8 billion in 2023 and is projected to reach USD 45.0 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period 2024–2032. Immune health ingredients, comprising vitamins, minerals, probiotics, prebiotics, botanical extracts, and specialized proteins, are bioactive compounds scientifically recognized for supporting and modulating the body's natural defense mechanisms. These ingredients are extensively incorporated into dietary supplements, functional foods and beverages, pharmaceuticals, and animal nutrition products. Their proven efficacy in enhancing immune resilience continues to drive their strategic importance across global health and wellness markets. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/12330/immune-health-ingredient-market

Rising Demand for Natural Supplements Fuels White Kidney Bean PE Market According to a newly published market research report by 24LifeSciences, global White Kidney Bean PE market was valued at USD 41.8 million in 2024 and is projected to reach USD 64.2 million by 2032, growing at a compound annual growth rate (CAGR) of 5.3% during the forecast period 2025–2032. White Kidney Bean PE (Phaseolus vulgaris extract), standardized to contain the active compound Phaseolamin, is a potent alpha-amylase inhibitor widely utilized as a natural starch blocker in nutritional supplements and functional foods. Its primary mechanism involves inhibiting the enzyme responsible for breaking down complex carbohydrates into simple sugars, thereby reducing carbohydrate absorption and caloric intake. This scientifically supported functionality underpins its established role in weight management formulations and blood sugar control supplements, making it a cornerstone ingredient in the global preventative health and wellness market. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/12197/white-kidney-bean-pe-market

CBD Gummies Market Growth Accelerates Amid Rising Plant-Based Wellness Demand The global CBD gummies market is experiencing extraordinary expansion, evolving from a niche supplement category to a mainstream wellness phenomenon driven by widening legal acceptance of hemp-derived products, massive consumer shifts toward non-combustible CBD consumption methods, and rising prevalence of anxiety and sleep disorders worldwide. According to comprehensive market research by The Insight Partners, the CBD gummies market was valued at US$ 5.89 billion in 2025 and is projected to reach an impressive US$ 33.19 billion by 2034, registering a remarkable compound annual growth rate (CAGR) of 20.5% during the forecast period from 2026 to 2034. Understanding CBD Gummies CBD gummies are cannabidiol-infused edible confections offering a familiar, candy-like consumption experience that eliminates the stigma and complexity associated with tinctures, vapes, or topicals. These products provide pre-measured, consistent CBD dosages in discreet formats appealing to "canna-curious" consumers hesitant about traditional cannabis delivery methods. The market encompasses both conventional formulations utilizing standard sweeteners and gelatin with traditional textures and flavor profiles, alongside rapidly expanding sugar-free variants catering to health-conscious consumers, diabetics, and those following specific dietary regimens who seek CBD benefits without caloric intake of traditional confectionery. Market Segmentation and Distribution Dynamics By category, conventional CBD gummies currently drive primary market volume, leveraging traditional confectionery formats with wide flavor variety and familiar textures. However, sugar-free formulations represent the fastest-growing segment, targeting health-conscious demographics through high-quality sugar substitutes while maintaining therapeutic CBD benefits. This segmentation reflects broader wellness industry trends toward "clean-label" products free from artificial ingredients and excessive sweeteners. Request Sample Pages of this Research Study @ https://www.theinsightpartners.com/sample/TIPRE00017402/ Key Market Drivers and Consumer Trends Three primary forces propel CBD gummies market expansion. First, convenience and discreet consumption advantages position gummies as socially acceptable wellness products consumable anywhere without stigma, appealing to general wellness populations seeking stress management and sleep support. Second, diversification of functional formulations incorporating minor cannabinoids including CBN for nighttime recovery and CBG for stress management expands total addressable markets through targeted health outcome positioning. Third, mainstream retail integration through major drugstore chains and grocery outlets significantly lowers purchase barriers through increased visibility and perceived legitimacy, transforming CBD from specialty wellness products to everyday health supplements. Regional Market Dynamics North America holds the largest global market share, supported by the 2018 Farm Bill establishing federal hemp legality and creating mature producer and retailer ecosystems. The region benefits from high consumer spending power, strong cultural wellness trends, and continuous product innovation in flavors, potencies, and minor cannabinoid blends. Europe represents a significant growing market though constrained by varying Novel Food regulations across EU and UK jurisdictions, with consumer interest rising in stress and anxiety management applications. Market Opportunities and Strategic Innovations Significant opportunities exist in professional sports and fitness niches positioning CBD gummies as natural recovery aids emphasizing anti-inflammatory benefits and pain management. Cross-border expansion into emerging legal markets in Europe and Latin America offers first-mover advantages as global trade barriers lower. Advanced functional integration combining CBD with vitamins, minerals, and adaptogens creates comprehensive wellness solutions differentiating premium product tiers. Key Market Players and Recent Developments Leading companies include Dixie Brands, Aurora Cannabis Inc., Canopy Growth Corporation, Sunday Scaries, Diamond CBD, CBD American Shaman, CV Sciences Inc., Medix CBD, and CBDFx. Notable recent developments include CV Sciences' November 2024 acquisition of Extract Labs integrating diverse CBD product lines and GMP-certified facilities, and Cronos Group's November 2025 Lord Jones brand expansion into Canadian markets with premium edible and inhalable innovations.

Leading Companies in Catheter Sheath Market to Watch by 2032 According to a newly published market research report by 24LifeSciences, global catheter sheath market was valued at USD 2.1 billion in 2024 and is projected to reach USD 3.5 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 2025–2032. Catheter sheaths, also known as introducer sheaths, are critical medical devices used to establish and maintain vascular access during minimally invasive procedures. These devices enable the safe insertion of catheters, guidewires, and other interventional tools while minimizing vessel trauma and blood loss. Essential applications span cardiology, radiology, urology, and vascular surgery, with key product variations including standard sheaths, leak-proof sheaths with integrated hemostatic valves, and peel-away sheaths designed for complex device delivery. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/11417/catheter-sheath-market

Top 7 Innovations Transforming the Non-absorbable Dural Patch Industry According to a newly published market research report by 24LifeSciences, global non-absorbable dural patch market was valued at USD 41.3 million in 2023 and is projected to reach USD 47.5 million by 2030, growing at a compound annual growth rate (CAGR) of 1.7% during the forecast period 2024-2030. Non-absorbable dural patches, fabricated from synthetic materials that remain intact within the body, are critical medical implants designed to repair and reinforce the dura materthe protective membrane surrounding the brain and spinal cord. These patches provide essential, long-term structural support following complex neurosurgical and spinal procedures. Their established role in preventing cerebrospinal fluid leaks and ensuring durable anatomical repair continues to underpin their indispensable status in modern surgical practice. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/3898/non-absorbable-dural-patch--global-outlook-and-market

Global Nasal Airway Splint Market to Grow at a CAGR of 3.4% Through 2034 According to a newly published market research report by 24LifeSciences, global nasal airway splint market was valued at USD 106 million in 2024 and is projected to reach USD 133 million by 2031, growing at a compound annual growth rate (CAGR) of 3.4% during the forecast period 2025–2031. Nasal airway splints are essential medical devices designed to provide septal support and maintain nasal patency during the post-operative healing phase. These devices, typically manufactured from medical-grade silicone or advanced bioabsorbable polymers like polylactic acid, offer either temporary mechanical support or gradual resorption that eliminates the need for removal procedures. The market is segmented into sterile and non-sterile product categories, with sterile variants dominating hospital settings due to stringent infection control requirements. From an application standpoint, hospitals account for the largest market share owing to higher volumes of rhinoplasty and nasal trauma procedures, while specialty clinics are experiencing rapid growth driven by the increasing shift toward outpatient surgery models. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/5467/nasal-airway-splint-market

Enteral Medicine Straw Market Size to Reach USD 5.8 Million by 2034 | Trends & Forecasts According to a newly published market research report by 24LifeSciences, global enteral medicine straw market was valued at USD 4.2 million in 2024 and is projected to reach USD 5.8 million by 2032, growing at a compound annual growth rate (CAGR) of 4.1% during the forecast period 2025–2032. Enteral medicine straws are specialized medical devices designed for the safe and accurate oral administration of liquid or powdered medication to patients with dysphagia or those reliant on enteral feeding tubes. These single-use, calibrated straws are critical for ensuring precise dosing, preventing tube occlusions, and minimizing contamination risks in both clinical and homecare settings. Their role in facilitating effective medication delivery for vulnerable patient populations underpins their essential position in supportive care management. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/10708/enteral-medise-straw-market